D. Euwart

Human cell lines for biopharmaceutical manufacturing: history, status, and future perspectives

J. Dumont, S. Estes, R. Kshirsagar, 2015, Critical reviews in biotechnology.

Recombinant factor IX-Fc fusion protein (rFIXFc) demonstrates safety and prolonged activity in a phase 1/2a study in hemophilia B patients.

A. Bitonti, J. Dumont, L. Valentino, 2012, Blood.

Validation of the manufacturing process used to produce long-acting recombinant factor IX Fc fusion protein

J. Dumont, K. Kobayashi, G. Pierce, 2014, Haemophilia : the official journal of the World Federation of Hemophilia.

Recombinant factor IX-Fc fusion protein (rFIXFc) demonstrates safety and prolonged activity in a phase 1/2a study in hemophilia B patients.

A. Bitonti, J. Dumont, L. Valentino, 2012, Blood.